Your existing multitool may be cool in an outdoorsy way, but does it give you any "street cred"? Well the WingSpan … might … as it packs an adjustable wrench ...

Two women aged 18 and 51 were killed and a third young woman wounded when a student carried out a knife attack at a school in eastern Slovakia. Local police initially said the suspect - an 18-year ...

That partner, Japan’s Nippon Shinyaku, is handing over $110 million upfront to lead on the commercialization of two gene therapies—RGX-121 for Hunter syndrome and RGX-111 for Hurler syndrome.

(RTTNews) - REGENXBIO Inc. (RGNX) and Nippon Shinyaku announced a strategic partnership for the development and commercialization of RGX-121 for the treatment of Mucopolysaccharidosis II ...

Valorant’s head of anti-cheat has confirmed that a big change is in the pipeline as they’re cracking down on the rise of hackers. When Valorant first launched, Riot Games boasted about their ...

Valorant is cracking down on hackers by implementing ranked rollbacks to reverse progress or rank if a match is affected by cheaters. The new measures are designed to penalize cheaters and promote ...

RGX-121 is poised to be the first gene therapy for MPS II with potential FDA approval as early as late 2025, and RGX-111 has demonstrated very promising results in Phase 1/2 study. With Nippon ...

One of the things that Riot Games promised at the start of Valorant's Season 2025 is that the competitive map pool will receive changes more often than in previous years. Keeping their word, the ...

In return for its investment, Nippon Shinyaku will gain access to two of Regenxbio’s gene therapies. The most mature of the assets is RGX-121, which is being tested for mucopolysaccharidosis type II, ...

and ROCKVILLE, Md., Jan. 13, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program. ABBV-RGX-314 in Wet Age ...

“ABBV-RGX-314 has the potential to help millions of people living with wet AMD and DR, globally, who are facing these debilitating diseases,” said Curran Simpson, president and chief executive officer ...